No racial difference in allele frequencies of FCGR3A gene F158V polymorphisms in diffuse large B-cell lymphoma

被引：2
|
作者：
Hirakawa, Tsuneaki
Yamaguchi, Hiroki [1 ]
Mitamura, Yoshio [2 ]
Kosaka, Fumiko
Dan, Kazuo
Inokuchi, Koiti
机构：
[1] Nippon Med Sch, Dept Internal Med, Div Hematol, Bunkyo Ku, Tokyo 1138603, Japan
[2] Sekino Clin Pharmacol Clin, Dept Internal Med, Tokyo, Japan
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2011年 / 86卷 / 02期
关键词：
FC-GAMMA-RIIIA; NON-HODGKINS-LYMPHOMA; V/F POLYMORPHISM; PREDICT RESPONSE; RITUXIMAB; CHOP;
D O I：
10.1111/j.1600-0609.2010.01554.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：180 / 181
页数：2
相关论文
共 50 条
  • [31] Human Leukocyte Antigen-G Polymorphisms Influence the Clinical Outcome in Diffuse Large B-Cell Lymphoma
    Bielska, Marta
    Bojo, Marcin
    Klimkiewicz-Wojciechowska, Gabriela
    Jesionek-Kupnicka, Dorota
    Borowiec, Maciej
    Kalinka-Warzocha, Ewa
    Prochorec-Sobieszek, Monika
    Robak, Tadeusz
    Warzocha, Krzysztof
    Mlynarski, Wojciech
    Lech-Maranda, Ewa
    GENES CHROMOSOMES & CANCER, 2015, 54 (03) : 185 - 193
  • [32] Gallbladder Involvement of Diffuse Large B-Cell Lymphoma with 18F-FDG PET/CT
    Arslan, Esra
    Alcin, Goksel
    Aksoy, Tamer
    Cermik, Tevfik Fikret
    TURKISH JOURNAL OF HEMATOLOGY, 2022, 39 (02) : 140 - 141
  • [33] The Effect of FcγRIIIA Gene Polymorphism on the Treatment of Diffuse Large B-cell Non-Hodgkin Lymphoma: A Multicenter Prospective Observational Study
    Buyukkurt, Nurhilal
    Ozcan, Mehmet Ali
    Ergene, Ulku
    Payzin, Bahriye
    Tunah, Sunay
    Demirkan, Fatih
    Ozsan, Hayri
    Piskin, Ozden
    Undar, Bulent
    TURKISH JOURNAL OF HEMATOLOGY, 2015, 32 (02) : 152 - 157
  • [34] Clinical significance of bone marrow involvement by immunoglobulin gene rearrangement in de novo diffuse large B-cell lymphoma: a multicenter retrospective study
    Kim, Yu Ri
    Shin, Ho Jin
    Yhim, Ho-Young
    Yang, Deok-Hwan
    Park, Yong
    Lee, Ji Hyun
    Lee, Won-Sik
    Do, Young Rok
    Mun, Yeung-Chul
    Kim, Dae Sik
    Kim, Jin Seok
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [35] MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma
    Olarte, Irma
    Martinez, Adolfo
    Ramos-Penafiel, Christian
    Castellanos-Sinco, Humberto
    Zamora, Jorge
    Collazo-Jaloma, Juan
    Gutierrez, Mario
    Gutierrez-Kobeh, Laila
    Chavez-Olmos, Pedro
    Manzanilla, Hugo
    Garrido-Guerrero, Efrain
    Ordonez-Razo, Rosa M.
    Miranda, Enrique I.
    HEMATOLOGY, 2011, 16 (06) : 368 - 372
  • [36] Evaluation of a five-gene signature associated with stromal infiltration for diffuse large B-cell lymphoma
    Nan, Ying-Yu
    Zhang, Wen-Jun
    Huang, De-Hong
    Li, Qi-Ying
    Shi, Yang
    Yang, Tao
    Liang, Xi-Ping
    Xiao, Chun-Yan
    Guo, Bing-Ling
    Xiang, Ying
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (18) : 4585 - 4598
  • [37] F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma
    Gallicchio, Rosj
    Mansueto, Giovanna
    Simeon, Vittorio
    Nardelli, Anna
    Guariglia, Roberto
    Capacchione, Daniela
    Soscia, Ernesto
    Pedicini, Piernicola
    Gattozzi, Domenico
    Musto, Pellegrino
    Storto, Giovanni
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (05) : 382 - 389
  • [38] mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma
    Xu, Wendan
    Berning, Philipp
    Erdmann, Tabea
    Grau, Michael
    Bettazova, Nardjas
    Zapukhlyak, Myroslav
    Frontzek, Fabian
    Kosnopfel, Corinna
    Lenz, Peter
    Grondine, Michael
    Willis, Brandon
    Lynch, James T.
    Klener, Pavel
    Hailfinger, Stephan
    Barry, Simon T.
    Lenz, Georg
    LEUKEMIA, 2023, 37 (01) : 178 - 189
  • [39] Outcome of Diffuse Large B-Cell Lymphoma in the United States Has Improved Over Time but Racial Disparities Remain: Review of SEER Data
    Komrokji, Rami S.
    Al Ali, Najla H.
    Beg, M. S.
    Safa, Malek M.
    Rollison, Dana
    Kharfan-Dabaja, Mohamed
    Bello, Celeste
    Cultrera, Jennifer
    Sokol, Lubomir
    Pinilla-Ibarz, Javier
    Sotomayor, Eduardo M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (03) : 257 - 260
  • [40] FCγRIIIA and FCγRIIA polymorphisms are not associated with response to rituximab and CHOP in patients with diffuse large B-cell lymphoma
    Mitrovic, Zdravko
    Aurer, Igor
    Radman, Ivo
    Ajdukovic, Radmila
    Sertic, Jadranka
    Labar, Boris
    HAEMATOLOGICA, 2007, 92 (07) : 998 - 999
12345